Expression of the chemokine CXCL14 and cetuximab-dependent tumour suppression in head and neck squamous cell carcinoma

Cetuximab, a monoclonal antibody against the epidermal growth factor receptor (EGFR), has been successfully used to treat some patients with colorectal cancer and those with head and neck squamous cell carcinoma (HNSCC). For the effective treatment, it is essential to first identify cetuximab-respon...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Oncogenesis
Hauptverfasser: Kondo, T, Ozawa, S, Ikoma, T, Yang, X-Y, Kanamori, K, Suzuki, K, Iwabuchi, H, Maehata, Y, Miyamoto, C, Taguchi, T, Kiyono, T, Kubota, E, Hata, R-I
Format: Artigo
Sprache:Inglês
Veröffentlicht: Nature Publishing Group 2016
Schlagworte:
Short Communication
Online Zugang:https://ncbi.nlm.nih.gov/pmc/articles/PMC5399171/
https://ncbi.nlm.nih.gov/pubmed/27399917
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/oncsis.2016.43
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!

Ähnliche Einträge